Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Gynecol Oncol. 2011 Feb 16;121(2):303–308. doi: 10.1016/j.ygyno.2011.01.030

Table 3.

A: Pre-Treatment EGFR IHC Protein Expression Characteristics; B: EGFR IHC Protein Expression and Disease Status; C: Tabulation Between PFS > 6 months and Percent Staining

IHC Measure n %
Intensity
1 14 30
2 10 21
3 23 49
P staining
High 25 52
Low 23 48
H-Value
High 25 52
Low 23 48
ADV
N(%)
RCS
N(%)
RCL
N(%)
Intensity
1 3 (27) 5 (25) 6 (37)
2 1 (9) 2 (10) 7 (44)
3 7 (64) 13 (65) 3 (19)
P Staining
High 7 (64) 15 (71) 3 (19)
Low 4 (36) 6 (29) 13 (81)
H-Value
High 8 (73) 14 (67) 3 (19)
Low 3 (27) 7 (33) 13 (81)
PFS> 6
P Staining Yes No
N (%) N (%)
High 5 (33) 20 (60)
Low 10 (67) 13 (40)
  • ADV= advanced; ReCurrent Short (RCS) = Persistent or PFI ≤ median; ReCurrent Long (RCL) = PFI > median
  • P Staining = dichotomy of percent staining at the median (0.81). If % staining ≥ 0.81, then P Staining =High.
  • H-value = dichotomy of H score (percentage × intensity) at the median (1.44). If H-score ≥ 1.44, then H-Value= High.